BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19410326)

  • 1. Balancing adoption and affordability of medical devices in Europe.
    Schreyögg J; Bäumler M; Busse R
    Health Policy; 2009 Oct; 92(2-3):218-24. PubMed ID: 19410326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical technology procurement in Europe: a cross-country comparison of current practice and policy.
    Sorenson C; Kanavos P
    Health Policy; 2011 Apr; 100(1):43-50. PubMed ID: 20846739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economics of medical devices: opportunities and challenges.
    Simoens S
    J Med Econ; 2008; 11(4):713-7. PubMed ID: 19450077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The limited state of technology assessment for medical devices: facing the issues.
    Ramsey SD; Luce BR; Deyo R; Franklin G
    Am J Manag Care; 1998 Sep; 4 Spec No():SP188-99. PubMed ID: 10185994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical device reimbursement coverage and pricing rules in Korea: current practice and issues with access to innovation.
    Lee SS; Salole E
    Value Health; 2014 Jun; 17(4):476-81. PubMed ID: 24969010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value.
    Sorenson C; Drummond M; Burns LR
    Health Aff (Millwood); 2013 Apr; 32(4):788-96. PubMed ID: 23569060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parameters for allocation of expensive medical devices (EMD) as a national regulatory mechanism].
    Tal O; Sheffer N; Vaknin S
    Harefuah; 2008 Apr; 147(4):359-62, 372. PubMed ID: 18686822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Marketing approval and market surveillance of medical devices in Germany: Where does policy integration take place?].
    Lang A
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(5-6):320-4. PubMed ID: 25066351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Better medical devices regulations for better health care: enlightenment for medical devices regulatory reform in China, from experiences of the E.U. and the U.S.A].
    Sun Q; Yan L
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Jan; 30(1):43-52. PubMed ID: 16646425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The financing and regulation of medical devices in the United States.
    Sisk JE
    Med Prog Technol; 1982; 9(2-3):181-6. PubMed ID: 7162490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From medical invention to clinical practice: the reimbursement challenge facing new device procedures and technology--part 3: payment.
    Raab GG; Parr DH
    J Am Coll Radiol; 2006 Nov; 3(11):842-50. PubMed ID: 17412183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The shape of European business in 2003.
    Wagner M
    Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520
    [No Abstract]   [Full Text] [Related]  

  • 15. Special funding schemes for innovative medical devices in French hospitals: the pros and cons of two different approaches.
    Martelli N; van den Brink H
    Health Policy; 2014 Jul; 117(1):1-5. PubMed ID: 24794738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Device evaluation and coverage policy in workers' compensation: examples from Washington State.
    Franklin GM; Lifka J; Milstein J
    Am J Manag Care; 1998 Sep; 4 Spec No():SP178-86. PubMed ID: 10185993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European medical device regulation: a new era?
    Donawa M
    Med Device Technol; 2004 Dec; 15(10):30-1. PubMed ID: 16225282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DRG-based hospital payment systems and technological innovation in 12 European countries.
    Scheller-Kreinsen D; Quentin W; Busse R
    Value Health; 2011 Dec; 14(8):1166-72. PubMed ID: 22152189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of emerging medical devices on the market: a new procedure in Belgium.
    Vinck I; Neyt M; Thiry N; Louagie M; Ramaekers D
    Int J Technol Assess Health Care; 2007; 23(4):449-54. PubMed ID: 17937833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Government health policy and the diffusion of new medical devices.
    Hillman BJ
    Health Serv Res; 1986 Dec; 21(5):681-711. PubMed ID: 3818311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.